This provider accepts the following insurance plans.
clinical trials, multiple system atrophy, autonomic failure, orthostatic hypotension, hereditary sensory and autonomic neuropathy, familial dysautonomia, autonomic autoimmune ganglionopathy, autonomic disorders
Dr. Palma's work over the past years has focused on the description of the autonomic phenotype and the search for biomarkers in patients with neurodegenerative autonomic disorders, including multiple system atrophy (MSA), Parkinson disease (PD) and pure autonomic failure (PAF).
Dr. Palma is one of the international coordinators of the Natural History Study of the Synucleinopathies. He is the principal or co-investigator in clinical trials for neurogenic orthostatic hypotension and multiple system atrophy as well as in the development of biomarkers of disease diagnosis and progression.
His work in rare diseases is also focused on genetic autonomic disorders. Dr. Palma is interested in defining the phenotype and genotype of and clinical trial design and conduct for familial dysautonomia (Riley-Day syndrome) and other rare hereditary sensory autonomic neuropathies (HSAN).
530 First Avenue
New York, NY 10016
A Phase 3 4-week Multicenter Randomized Double-blind Placebo-controlled Parallel-group Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure
Clinical autonomic research. 2021 Feb 07;
Journal of neurology. 2021 Jan 02;
Annals of neurology. 2020 Dec ; 88(6):1237-1243